Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-021271
Filing Date
2025-06-25
Accepted
2025-06-25 17:01:55
Documents
1
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4102
  Complete submission text file 0001437749-25-021271.txt   5837
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address
Poulton Jeffrey V. (Reporting) CIK: 0001782962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 251074371